"The results fundamentally alter scientists' understanding of how Alzheimer's harms the brain," researchers say.

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Making a 75-milligram vial available alongside the two current options of 200 milligrams and 500 milligrams could save ...

The neurodegenerative disorder affects millions of Americans, and its impact varies significantly across the country.

Tuesday, October 15 is L.A. Found Day in the county, marking the anniversary of the disappearance of a 56-year-old Manhattan ...

Heparin treatment was associated with a delayed diagnosis of Alzheimer's dementia, electronic health records in two U.S.

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Seltorexant is one of J&J’s most promising neuroscience candidates. The human orexin-2 receptor selective agonist produced ...

Admission not only includes performances by three comedians, Julie Lyons, Steve Smargon and Lietz, but good food, raffles, a ...

New research suggests the disease occurs in two phases, including one in which changes happen gradually – and 'quietly.' ...

On Oct. 19 Sacred Heart University will hold a 'Walk to End Alzheimer's' on the university campus in Fairfield, one of ...